TALS - Talaris Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-47.32M

Cash

165.8M

Avg Qtr Burn

-15.37M

Short % of Float

2.97%

Insider Ownership

13.49%

Institutional Own.

76.35%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
FCR001 Details Scleroderma	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
FCR001 Details Renal Transplantation	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.